A review on gastroretentive floating tablets of Quinapril HCl

Authors

  • Audumbar Digambar Mali Department of Pharmaceutics, Sahyadri College of Pharmacy, Methwade, Sangola- 413307, Solapur, Maharashtra, India.
  • Ritesh Suresh Bathe Department of Pharmaceutics, Sahyadri College of Pharmacy, Methwade, Sangola- 413307, Solapur, Maharashtra

DOI:

https://doi.org/10.7439/ijap.v3i2.2240

Abstract

Quinapril HCl is a prodrug that belongs to the angiotensin-converting enzyme (ACE) inhibitor class of medications. It is metabolized to quinaprilat (quinapril diacid) following oral administration. Quinaprilat is a competitive inhibitor ofACE, the enzyme responsible for the conversion of angiotensin I (ATI) to angiotensin II (ATII).ATIIregulates blood pressure and is a key component of the Renin-Angiotensin-Aldosterone System (RAAS). Quinapril hcl has a short biological half-life of 2 hrs with a prolonged terminal phase of 25 hours. So the floating tablet formulations are needed for Quinapril hcl to prolong its duration of action, to increase its oral bioavailability and to improve patient compliance . Many methods are used for preparing floating tablet preparations of Quinapril hcl by using various grades of Hydroxypropyl methyl celluloses (HPMC K4M, K15M, K100M) at various concentrations 10%, 20% and 30%. This review article comprises of the research materialized in the field of formulation and evaluation of floating tablets of Quinapril HCl.

Downloads

Download data is not yet available.

Author Biography

  • Audumbar Digambar Mali, Department of Pharmaceutics, Sahyadri College of Pharmacy, Methwade, Sangola- 413307, Solapur, Maharashtra, India.
    Pharmaceutics Department and First rank in solapur university,solapur.

Downloads

Published

2014-07-09

Issue

Vol. 3 No. 2 (2014): Mar-Apr

Section

Review Article

License

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).

How to Cite

1.
A review on gastroretentive floating tablets of Quinapril HCl. Int J Adv Pharm [Internet]. 2014 Jul. 9 [cited 2026 Jan. 3];3(2):28-31. Available from: https://ssjournals.co.in/index.php/ijap/article/view/2240
Crossref
Scopus
Google Scholar
Europe PMC